Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wockhardt's Insulin Analogue vs Lantus in Type 1 Diabetes
NCT01352663Phase 3Withdrawn
- Sponsor
- Wockhardt
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of insulin glargine in type 1 diabetes mellitus (T1D), sponsored by Wockhardt. Status: withdrawn.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01352663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01352663.